Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

By Natalie Morrison

- Last updated on GMT

Related tags: European union, Vp, Executive director

The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July will put Europe on an equal playing field, according to Clinipace’s Andrea Schiefer.

Speaking to Outsourcing-Pharma.com, the firm's VP of European clinical operations and executive director of pharmacovigilance said the directive will correct the mistakes of the past that have caused a reduction of clinical trials in Europe.

When asked if it is ethical to make one market very attractive for conducting trials, she said: “I don’t think it will lead to a great influx in trials. It will be a slow development and it will make it more proportionate and more fair compared to the situation now.”

Schiefer added that if anything, the EC could have implemented more scientific expert committees looking at certain indications when forming the new guidelines.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us

Products

View more

Webinars